Dermata Therapeutics, Inc. DRMA 深 滬
已收盤 09-19 16:00:00 美东时间
1.75
-0.500
-22.22%
華盛通- 最 高2.30
- 今 開2.28
- 成交量 48.78万股
- 最 低 1.75
- 昨 收 2.25
- 總市值 77.72万
- 52周最高 16.80
- 市盈率 靜 --
- 換手率 109.84%
- 52周最低 1.29
- 委 比 -40.27%
- 總股本 44.41万
- 歷史最高 1668.00
- 量 比 0.09
- 振 幅 24.44%
- 歷史最低 1.75
- 每 手 1
- 風險率 3.93%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Reported Earlier, Dermata Therapeutics Raises $3.5M Through Private Placement, Offering 1.9M Shares And Warrants
The gross proceeds from the offering are expected to be approximately $3.5 million, prior to deducting placement agent's fees and other offering expenses payable by the Company. The Company intends to use
09-17 15:07
Dermata Therapeutics prices $3.5M equity offering
Late-stage biotechnology company focused on the treatment of medical and aesthetic skin diseases - Dermata Therapeutics (NASDAQ:DRMA) announced the sale of 1.91M shares and warrants to purchase shares...
09-17 12:54
伊芙美尔医疗盘中异动 下午盘大幅下跌6.33%
北京时间2024年09月13日02时21分，伊芙美尔医疗（ICCC.us）股票出现波动，股价大幅下挫6.33%。截至发稿，该股报3.55美元/股，成交量13....
09-13 02:21
Dermata Therapeutics share are trading higher. The company reported Q2 financial results.
Dermata Therapeutics share are trading higher. The company reported Q2 financia...
08-09 03:24
Dermata Therapeutics Q2 EPS $(4.18) Misses $(3.79) Estimate
Dermata Therapeutics (NASDAQ:DRMA) reported quarterly losses of $(4.18) per share which missed the analyst consensus estimate of $(3.79) by 10.29 percent. This is a 55.77 percent increase over losses of $(9.45) per share
08-08 04:33
Peering Into Dermata Therapeutics's Recent Short Interest
Dermata Therapeutics's (NYSE:DRMA) short percent of float has risen 141.25% sin...
08-08 04:00
3 Penny Stocks to Watch Now, 8/6/24
VSee Health, Dermata Therapeutics, and Exicure, Inc. are the 3 Penny Stocks to ...
08-06 18:14
Why Enphase Energy Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Shares of Enphase Energy, Inc. (NASDAQ:ENPH) rose sharply in today's pre-market...
07-24 17:27
快讯 | Dermata Therapeutics公司- 科创板-1的头等结果预计在2025年第1季度公布。
Dermata Therapeutics Inc - Star-1 Topline Results Expected in Q1 of 2025
07-17 21:08
